3Hogot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine -rich repeat variants with susceptibility to Cvohn's disease. Nature,2001, 411: 599-603.
4Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 2001, 411 :603 -606.
5Hampe J, Cuthbert A, Crouche PJ, et al, Association between insertion mutation in NOIY2 gene and Crohn's disease in German and British population.Lancet, 2001, 357:1925-1928.
6L Laghi, S. Costa, S. Saibeni, et al. Carriage of CARD15 variants and smoking as risk factor for resective surgery in patients with Crohn's ileal disease. Aliment Pharmacol Ther, 2005, 22:557 -564.
7Barton JR, Raid MA Gaze MN, et al. Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours. Gut,1990, 31 : 378 -382.
8Hatoum OA, Binion DG, Otterson MF, et al, Acquired microvascular dysfunction in inflammatory bowel disease: loss nitric oxide - mediated vasodolatation. Gastroenterology, 2003, 125 : 58 - 69.
9Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Pathogenesis of Crohn" s disease: multifocal gastrointestinal infarction. Lancet, 1989, 2: 1057 - 1062.
10Censer D, Kang MH, Vogelsang H, et al, Status of lipid solible antioxidants and TRAP in patients with Crohn "s disease and healthy controls, Eur J Clin Nutr, 1999, 53:675 -679.
6Zheng JJ,Zhu XS,Huangfu Z,et al.Crohn's disease in China's Mainland:a system atie analysis of 50 years of research[J]. Chin J Dig Dis,2005,6 (4) : 175-181.
7Jee jeebhoy KN. The many faces of malnutrition in crohn disease[J].Am J C lin Nutr,1998,67(5):819-820.
8王雅琴.克罗恩病的观察与护理.护理研究,2000,21(6):38-38.
9Robert N, David A. Inflammatory Bowel Disease in Pediatric and Adolescent Patients[ J ]. Gast Roenterol Clin North Am, 1999,28:445.